The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs - PubMed
. 1987 Jun;147(6):1054-9.
- PMID: 3496062
The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs
J L Carson et al. Arch Intern Med. 1987 Jun.
Abstract
To assess the relative rate or upper gastrointestinal (UGI) tract bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs), we performed a retrospective cohort study using 1980 billing data from all Medicaid patients in the states of Michigan and Minnesota. The rate of UGI tract bleeding in the 30 days following each drug exposure was examined in the 88,044 patients dispensed only one of seven NSAIDs. The rate of UGI tract bleeding differed significantly among users of these drugs. Stratification and logistic regression were used to adjust for multiple potential confounding factors, without substantive changes in the results. An alcohol-drug interaction was found. Sulindac users had the highest rate of UGI tract bleeding, and it was the only drug statistically different from ibuprofen. When the average daily dose of sulindac received was divided by the maximum recommended daily dose, it was notably higher than those for other drugs. Repeated analyses using data from 1982 confirmed these results. We conclude that there are significant and consistent differences in the incidence of UGI tract bleeding associated with the use of NSAIDs in this population.
Similar articles
-
The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding.
Carson JL, Strom BL, Soper KA, West SL, Morse ML. Carson JL, et al. Arch Intern Med. 1987 Jan;147(1):85-8. Arch Intern Med. 1987. PMID: 3492182
-
Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Sturkenboom MC, et al. Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31. doi: 10.1093/rheumatology/keg495. Rheumatology (Oxford). 2003. PMID: 14585915
-
A case study: nonsteroidal antiinflammatory drugs and gastrointestinal bleeding.
Carson JL. Carson JL. J Rheumatol Suppl. 1988 Oct;17:24-7. J Rheumatol Suppl. 1988. PMID: 3264583
-
Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
Lanas A. Lanas A. Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S37-42. Ital J Gastroenterol Hepatol. 1999. PMID: 10379468 Review.
-
Moore RA, Derry S, Phillips CJ, McQuay HJ. Moore RA, et al. BMC Musculoskelet Disord. 2006 Oct 20;7:79. doi: 10.1186/1471-2474-7-79. BMC Musculoskelet Disord. 2006. PMID: 17054784 Free PMC article. Review.
Cited by
-
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA, Langtry HD, Buckley MM. Friedel HA, et al. Drugs. 1993 Jan;45(1):131-56. doi: 10.2165/00003495-199345010-00009. Drugs. 1993. PMID: 7680981
-
Lanza FL, Arnold JD. Lanza FL, et al. Clin Rheumatol. 1989 Mar;8 Suppl 1:5-15. doi: 10.1007/BF02214105. Clin Rheumatol. 1989. PMID: 2525983 Review.
-
Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.
Szabo S, Spill WF, Rainsford KD. Szabo S, et al. Med Toxicol Adverse Drug Exp. 1989 Mar-Apr;4(2):77-94. doi: 10.1007/BF03259905. Med Toxicol Adverse Drug Exp. 1989. PMID: 2654544 Review. No abstract available.
-
Pharmacoeconomics of chronic nonmalignant pain.
Zagari MJ, Mazonson PD, Longton WC. Zagari MJ, et al. Pharmacoeconomics. 1996 Oct;10(4):356-77. doi: 10.2165/00019053-199610040-00005. Pharmacoeconomics. 1996. PMID: 10163578 Review.
-
Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
Nash J, Lambert L, Deakin M. Nash J, et al. Drugs. 1994 Jun;47(6):862-71. doi: 10.2165/00003495-199447060-00002. Drugs. 1994. PMID: 7521828 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical